Knight Frank to be Gold Sponsor for the upcoming Life Sciences Real Estate Summit in Sydney

It will feature a series of insightful sessions and panel discussions, including the keynote presentation on "The Rise of Life Sciences in Australia" delivered by Bart Price, CEO, Vita Partners, and opening panel moderation by Lawson Katiza, Partner, Life Sciences, Knight Frank, an industry leader fireside chat on “Future Proofing Life Science Real Estate” between John Ratcliffe, CIO, Altea Investment and Sam Biggins, Partner, National Head of Healthcare and Life Sciences, Knight Frank and a case study on Queensland’s Knowledge Corridor & Boggo Road Innovation Precinct.

Attendees will gain valuable insights into the latest trends, regulatory considerations, and investment strategies shaping the future of life sciences real estate. The event provides unparalleled networking opportunities, fostering collaboration and innovation within the life sciences real estate community.

In the days following the summit, Lawson Katiza and Sam Biggins are excited to be hosting Knight Frank’s 2025 Life Sciences & Innovation Precincts Study Tour in the Netherlands.

The Knight Frank Study Tour, running from September 8 to 12, offers a unique opportunity to explore the Dutch Life Sciences industry, renowned for its progressive infrastructure and thriving science parks. Participants will connect with industry leaders, gain insights into best practices, and expand their global networks.

The tour includes visits to key locations such as Amsterdam Science Park, Leiden Bio Science Park and Brainport Industries Campus, providing a comprehensive understanding of the Dutch model and its applications to the Australian context.

Knight Frank National Head of Healthcare and Life Sciences in Australia Sam Biggins said Knight Frank was committed to supporting the growth and development of Australia's Life Sciences sector.

“These initiatives are testament to our dedication to excellence and industry leadership,” he said.

“The Life Sciences Real Estate sector is growing in Australia, following the flow of capital into the sector in leading global markets such as the UK’s Golden Triangle, Europe and key US markets.  Institutional investment in Australia’s healthcare and life sciences sectors has gathered significant momentum in recent years, driven initially by domestic investors seeking sector exposure, and now sees strong market participation by regional and global sector specialists and their capital partners.

Australia ranks in the top 1% globally for scientific research in sectors such as physics, space science and clinical medicine, yet as low as 40th for commercialisation.  The development of appropriate real estate infrastructure and curation of domestic innovation ecosystems is key to bridging the ‘valley of death’, creating deeper local talent pools and commercialising Australian research and innovation onshore.”

Contact Sam Biggins on 0410 979 075 and Lawson Katiza on 0403 856 651 for additional information on the September 2025 Knight Frank Netherlands Study Tour or to attend the Life Sciences Real Estate Summit.